Results 131 to 140 of about 3,512,284 (307)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen +7 more
wiley +1 more source
A Systematic Review and Meta‐Analysis of the Recurrence of Autoimmune Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Autoimmune encephalitis (AE) is a disease with a potential for recurrence, and patients receive immunotherapy to prevent it. However, there is no consensus on the duration of immunotherapy. This study aimed to determine the recurrence rate and identify the risk factors for AE to provide guidance on the duration of immunotherapy ...
Shangkai Bai +5 more
wiley +1 more source
Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li +10 more
wiley +1 more source
Cancer incidence and 5-year survival among Asian/Pacific Islanders, United States\u20142008\u20132017 [PDF]
During 2008 to 2017, cancer incidence rates among the Asian/Pacific Islander population decreased from 338.2 to 285.4 cases per 100,000 males compared with 294.6 to 287.4 cases per 100,000 females.Suggested citation: Centers for Disease Control and ...
core
Radiation oncology areas of need: cancer incidence projections 2014-2024 [PDF]
, 2014 Summary: Cancer incidence in Australia is projected to rise due to an expected increase in both the underlying cancer rates and in the Australian population over the age of 65.
core
Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli +5 more
wiley +1 more source
Incidence of malignant melanoma of the skin\u2013United States, 2009\u20132018 [PDF]
In 2018, a total of 83,996 new cases of melanoma were reported in the United States: 49,547 among males and 34,449 among females. The incidence rate was 22.0 per 100,000 standard population, 27.9 per 100,000 males, and 17.7 per 100,000 females.Invasive ...
core
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Annals of Clinical and Translational Neurology, EarlyView.Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Prostate Cancer Incidence by Stage at Diagnosis, United States\u20142001 122019 [PDF]
In 2019, a total of 224,733 new cases of prostate cancer were reported in the United States. The incidence rate was 112 per 100,000 males. Most cases of prostate cancer (70%) were diagnosed at the local stage.Aside from non-melanoma skin cancer, prostate
core